National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Lichen planus pigmentosus


Información en español


Other Names:
LP pigmentosus; Lichen planus pigmentosa; LP pigmentosa; LP pigmentosus; Lichen planus pigmentosa; LP pigmentosa; Lichen planus pigmentosus inversus See More
Categories:
This disease is grouped under:

Lichen planus pigmentosus (LPP) is a rare form of lichen planus. It is characterized by oval or irregularly-shaped brown to gray-brown macules and patches on the skin. Areas that are exposed to sun such as the forehead, temples and neck are most commonly affected. However, the macules and patches may also develop on the trunk or in places where two areas of skin touch or rub together (i.e. the armpit, groin, etc). LPP is a chronic, relapsing condition with periods of worsening symptoms separated by periods of remission (decreasing or disappearing symptoms). The cause of LPP is unknown, but studies suggest it may be triggered by UV light, viral infections, or agents applied to the skin such as mustard oil and amla oil. Treatment for LPP depends on the symptoms in each person.[1][2][3]
Last updated: 11/8/2016

Lichen planus pigmentosus (LPP) is characterized by oval or irregularly-shaped brown to gray-brown macules and patches on the skin. Areas that are exposed to sun such as the forehead, temples and neck are most commonly affected. However, the macules and patches may also develop on the trunk or in places where two areas of skin touch or rub together (i.e. the armpit, groin, etc). LPP is a chronic, relapsing condition with periods of exacerbations (worsening symptoms) separated by periods of remission (a decrease in or disappearance of symptoms).[1][2][4]

Although there usually are not other symptoms, some people may experience mild itching and/or burning, or develop other features of lichen planus. Please click here to learn more about the signs and symptoms that may be found in lichen planus.[1]

LPP usually affects young to middle-aged adults who have dark skin, especially those of Indian, Latin American, or Middle Eastern descent.[1]
Last updated: 11/8/2016

The underlying cause of lichen planus pigmentosus is currently unknown. However, studies suggest that the condition may be triggered by viral infections, UV light or the application of certain oils to the hair or skin (i.e. mustard oil, amla oil, or henna hair dyes).[1][2]
Last updated: 11/8/2016

A diagnosis of lichen planus pigmentosus is usually suspected based on the presence of characteristic signs and symptoms. A skin biopsy may then be ordered to confirm the diagnosis.[1][3]
Last updated: 11/8/2016

There is currently no consensus about treatment for lichen planus pigmentosus (LPP). Management includes avoiding things that make it worse in each case, such as sun exposure or friction in body folds (via weight loss or wearing loose clothing).[5]

No treatment options have shown consistent responses, and evidence of successful treatment has been limited to a few case series.[5] Treatment options may include:[1][4][6][7][8] In some cases, LPP goes away on its own within weeks. In other cases, pigmentation persists for years.[1][5]
Last updated: 2/22/2017

The long-term outlook (prognosis) for people with lichen planus pigmentosus (LPP) is generally good. Aside from the characteristic macules and patches on the skin, many people do not have any other symptoms. In those who do experience itching and/or burning of the skin or other features of lichen planus, symptoms usually improve with treatment. Unfortunately, LPP is generally a chronic, relapsing condition with periods of exacerbations (worsening symptoms) separated by periods of remission (a decrease in or disappearance of symptoms).[1][2]
Last updated: 11/8/2016

Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Clinical Research Resources

  • ClinicalTrials.gov lists trials that are related to Lichen planus pigmentosus. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

    Please note: Studies listed on the ClinicalTrials.gov website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.

These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

Where to Start

  • DermNet NZ is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.

In-Depth Information

  • Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Lichen planus pigmentosus. Click on the link to view a sample search on this topic.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.


  1. Vashi N & Kundu R. Approach to the patient with hyperpigmentation disorders. UpToDate. January 2015; http://www.uptodate.com/contents/approach-to-the-patient-with-hyperpigmentation-disorders.
  2. Lichen planus pigmentosus. Orphanet. May 2011; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=254463.
  3. Lichen planus. DermNet NZ. March 2015; http://dermnetnz.org/scaly/lichen-planus.html.
  4. Van R. Lichen planus pigmentosus. Dermatology Online Journal. 19(12):https://escholarship.org/uc/item/1tk5s24q.
  5. Irene Mathews, Devinder Mohan Thappa, Nidhi Singh, Debasis Gochhait. Lichen planus pigmentosus: A short review. Pigment International. 2016; 3(1):5-10. http://www.pigmentinternational.com/article.asp?issn=2349-5847;year=2016;volume=3;issue=1;spage=5;epage=10;aulast=Mathews.
  6. Han XD, Goh CL. A case of lichen planus pigmentosus that was recalcitrant to topical treatment responding to pigment laser treatment. Dermatol Ther. September-October 2014; 27(5):264-267. http://www.ncbi.nlm.nih.gov/pubmed/24796489.
  7. Al-Mutairi N, El-Khalawany M.. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol. May 2010; 24(5):535-540. https://www.ncbi.nlm.nih.gov/pubmed/?term=19840200.
  8. Ghosh A, Coondoo A. Lichen Planus Pigmentosus: The Controversial Consensus. Indian Journal of Dermatology. September-October 2016; 61(5):482-486. https://www.ncbi.nlm.nih.gov/pubmed/27688435.